Your browser is no longer supported. Please, upgrade your browser.
Settings
VIVO Meridian Bioscience, Inc. daily Stock Chart
VIVO [NASD]
Meridian Bioscience, Inc.
Index- P/E36.62 EPS (ttm)0.53 Insider Own0.10% Shs Outstand42.20M Perf Week-1.57%
Market Cap819.10M Forward P/E23.87 EPS next Y0.81 Insider Trans-43.96% Shs Float41.69M Perf Month24.74%
Income22.60M PEG2.15 EPS next Q0.17 Inst Own92.10% Short Float9.33% Perf Quarter27.70%
Sales210.20M P/S3.90 EPS this Y-33.40% Inst Trans0.29% Short Ratio14.37 Perf Half Y31.15%
Book/sh4.14 P/B4.69 EPS next Y7.26% ROA7.00% Target Price16.67 Perf Year29.83%
Cash/sh1.37 P/C14.15 EPS next 5Y17.00% ROE10.10% 52W Range13.53 - 19.84 Perf YTD38.64%
Dividend0.50 P/FCF178.07 EPS past 5Y-8.80% ROI10.00% 52W High-2.17% Beta0.65
Dividend %2.58% Quick Ratio3.90 Sales past 5Y3.10% Gross Margin61.40% 52W Low43.49% ATR0.65
Employees640 Current Ratio5.70 Sales Q/Q3.20% Oper. Margin13.70% RSI (14)82.47 Volatility3.62% 3.40%
OptionableYes Debt/Eq0.29 EPS Q/Q2743.80% Profit Margin8.40% Rel Volume3.17 Prev Close19.41
ShortableYes LT Debt/Eq0.26 EarningsNov 08 BMO Payout120.40% Avg Volume270.57K Price19.41
Recom3.20 SMA2013.39% SMA5021.80% SMA20027.27% Volume857,897 Change0.00%
Jan-26-18Reiterated Canaccord Genuity Hold $14 → $16
Mar-28-17Initiated CL King Neutral
Mar-28-16Reiterated Canaccord Genuity Hold $18 → $19
Sep-10-15Reiterated Canaccord Genuity Hold $19 → $18
Jul-27-15Reiterated Canaccord Genuity Hold $20 → $19
May-04-15Reiterated Canaccord Genuity Hold $19 → $20
Nov-06-14Downgrade Robert W. Baird Outperform → Neutral $22 → $22
Jul-27-12Downgrade Canaccord Genuity Buy → Hold
Apr-25-11Upgrade Wedbush Underperform → Neutral $18 → $22
Mar-24-11Upgrade Canaccord Genuity Hold → Buy $30
Nov-16-10Initiated Canaccord Genuity Hold $21
Apr-07-10Initiated Wedbush Underperform $18
Nov-13-09Reiterated Caris & Company Average $21 → $20
Jul-07-09Initiated Caris & Company Average $21
Mar-06-09Initiated William Blair Mkt Perform
Oct-14-08Initiated Lazard Capital Buy $30
Jul-21-08Upgrade Hilliard Lyons Neutral → Long-term Buy
May-14-08Initiated Susquehanna Financial Neutral
May-13-08Initiated CL King Accumulate
Apr-16-07Downgrade Hilliard Lyons Long-term Buy → Neutral
Nov-14-18 05:47PM  Edited Transcript of VIVO earnings conference call or presentation 8-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Nov-13-18 07:34AM  Meridian Bioscience Inc (NASDAQ:VIVO) Will Pay US$0.13 In Dividends Simply Wall St.
Nov-12-18 11:35AM  What Are Analysts Saying About Meridian Bioscience Incs (NASDAQ:VIVO) Earnings Outlook? Simply Wall St.
Nov-08-18 09:40AM  Meridian Bioscience (VIVO) Q4 Earnings and Revenues Beat Estimates Zacks +15.61%
08:43AM  Meridian Bioscience: Fiscal 4Q Earnings Snapshot Associated Press
07:30AM  Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance GlobeNewswire
Oct-22-18 12:08PM  What Does Meridian Bioscience Incs (NASDAQ:VIVO) PE Ratio Tell You? Simply Wall St.
Oct-19-18 08:40AM  New Research Coverage Highlights TIER REIT, Meridian Bioscience, ArQule, Greenlight Capital Re, ADT, and Turquoise Hill Resources Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-17-18 05:48PM  Meridian Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on November 8, 2018 GlobeNewswire
Oct-09-18 04:05PM  DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom GlobeNewswire
Sep-26-18 09:02AM  Meridian Bioscience Inc (NASDAQ:VIVO): The Yield That Matters The Most Simply Wall St.
Sep-24-18 04:00PM  Meridian Bioscience Announces Retirement of John A. Kraeutler, Executive Chairman of the Board; Appoints David C. Phillips as Chairman of the Board; and Elects Felicia Williams to the Board of Directors GlobeNewswire
Sep-02-18 09:30AM  Should Meridian Bioscience Inc (NASDAQ:VIVO) Be Part Of Your Dividend Portfolio? Simply Wall St.
Aug-16-18 01:27PM  A Look At The Fair Value Of Meridian Bioscience Inc (NASDAQ:VIVO) Simply Wall St.
Jul-31-18 08:50AM  Meridian Bioscience (VIVO) Q3 Earnings Beat Estimates Zacks
07:42AM  Meridian Bioscience: Fiscal 3Q Earnings Snapshot Associated Press
07:30AM  Meridian Bioscience Reports Third Quarter 2018 Operating Results, Declares Regular Third Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance GlobeNewswire
Jul-24-18 11:00AM  Quartzy joins with Bioline, Biotium, and MP Biomedicals to create the most diverse digital catalog of lab supplies in the nation GlobeNewswire
Jun-28-18 11:00AM  Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018 GlobeNewswire
Jun-21-18 02:03PM  With A -41.16% Earnings Drop, Is Meridian Bioscience Incs (NASDAQ:VIVO) A Concern? Simply Wall St.
May-30-18 02:12PM  Meridian's new CEO is reshaping culture to lay groundwork for growth American City Business Journals
10:54AM  Meridian Introduces Critical Raw Materials for Nipah Virus Diagnosis, a Key Emerging Disease on the WHOs Priority List GlobeNewswire
May-29-18 08:15AM  Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-30-18 02:58PM  Is Buying Meridian Bioscience Inc (NASDAQ:VIVO) For Its Upcoming $0.13 Dividend A Good Choice? Simply Wall St.
Apr-26-18 10:14AM  Meridian Bioscience: Fiscal 2Q Earnings Snapshot Associated Press
07:30AM  Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance GlobeNewswire
Apr-05-18 08:25AM  Research Report Identifies Meridian Bioscience, Baozun, MAG Silver, Heritage-Crystal Clean, Och-Ziff Capital Management Group, and EP Energy with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-04-18 10:00AM  Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal Year 2018 Operating Results on Thursday, April 26, 2018 GlobeNewswire
Mar-21-18 07:30AM  Meridian Bioscience Realigns Organizational Structure GlobeNewswire
Feb-12-18 09:15AM  Lawsuit for Investors in Meridian Bioscience, Inc. (NASDAQ: VIVO) Shares Announced by Shareholders Foundation ACCESSWIRE
Feb-09-18 05:02AM  Top NasdaqGS Healthcare Dividend Paying Companies Simply Wall St.
Feb-06-18 08:10AM  New Research: Key Drivers of Growth for Tallgrass Energy GP, LP, Lithia Motors, Akcea Therapeutics, Meridian Bioscience, Myomo, and Liberty Media Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-05-18 07:00AM  Free Post Earnings Research Report: Meridians Quarterly Revenue Grew 12%; Non-GAAP Earnings Advanced 4% ACCESSWIRE
Jan-25-18 07:30AM  Meridian Bioscience beats 1Q profit forecasts Associated Press +9.46%
07:15AM  Meridian Bioscience Reports First Quarter 2018 Operating Results, Declares Regular First Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance GlobeNewswire
Jan-19-18 10:50PM  MERIDIAN BIOSCIENCE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. VIVO Business Wire
04:23PM  Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018 GlobeNewswire
Jan-16-18 10:51AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline - January 16, 2018 ACCESSWIRE
Jan-15-18 11:00AM  The Klein Law Firm Reminds Investors of Commencement of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO) ACCESSWIRE
Jan-12-18 10:50PM  MERIDIAN BIOSCIENCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. - VIVO PR Newswire
09:35PM  Glancy Prongay & Murray Reminds Investors of the January 16, 2018 Deadline in the Class Action Lawsuit Against Meridian Bioscience, Inc. (VIVO) Business Wire
04:49PM  UPCOMING DEADLINE: The Klein Law Firm Reminds Investors of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO) ACCESSWIRE
03:48PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO ACCESSWIRE
Jan-11-18 04:00PM  Greater Cincinnati firm faces lawsuits linked to FDA warning, stock dip American City Business Journals
01:30PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO ACCESSWIRE
Jan-10-18 02:41PM  VIVO INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Meridian Bioscience, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
Jan-09-18 11:45AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO ACCESSWIRE
10:50AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline - January 16, 2018 ACCESSWIRE
Jan-08-18 03:00PM  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO) GlobeNewswire
01:10PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Meridian Bioscience, Inc. Investors and Encourages Investors to Contact the Firm (VIVO) Business Wire
10:13AM  VIVO LOSS NOTICE: Rosen Law Firm Reminds Meridian Bioscience, Inc. Investors of Important Deadline in Class Action VIVO GlobeNewswire
Jan-05-18 10:50PM  MERIDIAN BIOSCIENCE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. VIVO Business Wire
04:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO ACCESSWIRE
02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO ACCESSWIRE
Jan-04-18 08:00AM  VIVO EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Meridian Bioscience, Inc. and a Lead Plaintiff Deadline of January 16, 2018 GlobeNewswire
Jan-03-18 07:16PM  VIVO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Meridian Bioscience, Inc. Investors Business Wire
02:24PM  FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. (NASDAQ: VIVO) To Contact The Firm GlobeNewswire
12:18PM  EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO ACCESSWIRE
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline - January 16, 2018 GlobeNewswire
Jan-02-18 11:40AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO ACCESSWIRE
10:10AM  Scott+Scott, Attorneys at Law, LLP is Investigating Derivative Claims on Behalf of Shareholders of Meridian Bioscience, Inc. Business Wire
Dec-29-17 01:50PM  VIVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Meridian Bioscience, Inc. and a Lead Plaintiff Deadline of January 16, 2018 ACCESSWIRE
Dec-28-17 03:28PM  Lifshitz & Miller LLP Announces Investigation of Aqua Metals, Inc., Bonanza Creek Energy Inc., Meridian Bioscience, Inc., Mitsubishi UFJ Financial Group, Inc., Philip Morris International Inc., Quantenna Communications, Inc. and The Crypto Company PR Newswire
01:57PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO ACCESSWIRE
Dec-27-17 08:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO ACCESSWIRE
12:47PM  The Klein Law Firm Reminds Investors of Commencement of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 Business Wire
Dec-26-17 09:05AM  VIVO LOSS ALERT: Rosen Law Firm Reminds Meridian Bioscience, Inc. Investors of Important Deadline in Class Action VIVO GlobeNewswire
Dec-19-17 02:00AM  VIVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Meridian Bioscience, Inc. and a Lead Plaintiff Deadline of January 16, 2018 Business Wire
Dec-18-17 03:04PM  DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Meridian Bioscience, Inc. to Contact the Firm Business Wire
02:44PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 Business Wire
02:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO ACCESSWIRE
10:50AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline: January 16, 2018 ACCESSWIRE
Dec-15-17 09:10PM  Robbins Arroyo LLP is Investigating the Officers and Directors of Meridian Bioscience, Inc. (VIVO) on Behalf of Shareholders Business Wire +5.17%
02:13PM  ETFs with exposure to Meridian Bioscience, Inc. : December 15, 2017 Capital Cube
Dec-12-17 05:16PM  The Klein Law Firm Notifies Investors of Commencement of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 Business Wire
05:11PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Meridian Bioscience, Inc. VIVO GlobeNewswire
04:23PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO PR Newswire
Dec-11-17 03:00PM  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO) GlobeNewswire
10:49AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline: January 16, 2018 ACCESSWIRE
09:14AM  Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q4, 2017 By the Numbers : December 11, 2017 Capital Cube
Dec-08-17 02:55PM  VIVO EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Meridian Bioscience, Inc. and a Lead Plaintiff Deadline of January 16, 2018 Business Wire
02:14PM  VIVO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Meridian Bioscience, Inc. Investors Business Wire
Dec-05-17 01:24PM  ETFs with exposure to Meridian Bioscience, Inc. : December 5, 2017 Capital Cube
Dec-04-17 04:26PM  VIVO INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Meridian Bioscience, Inc. and a Lead Plaintiff Deadline of January 16, 2018 GlobeNewswire
01:21PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. (NASDAQ: VIVO) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
10:48AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) and Lead Plaintiff Deadline: January 16, 2018 ACCESSWIRE
Dec-01-17 09:36AM  Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: 2017 By the Numbers : December 1, 2017 Capital Cube
02:30AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO GlobeNewswire
Nov-30-17 04:35PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Nov-29-17 09:48AM  Meridian Bioscience Inc (VIVO) Files 10-K for the Fiscal Year Ended on September 30, 2017 GuruFocus.com
Nov-28-17 02:54PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Meridian Bioscience, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2018 VIVO Business Wire
02:48PM  VIVO LOSS NOTICE: Rosen Law Firm Reminds Meridian Bioscience, Inc. Investors of Important Deadline in Class Action VIVO Business Wire
10:46AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) and Lead Plaintiff Deadline: January 16, 2018 ACCESSWIRE
07:50AM  Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : November 28, 2017 Capital Cube
Nov-22-17 02:30PM  The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Meridian Bioscience, Inc. Business Wire
Nov-21-17 05:34PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Meridian Bioscience, Inc. Business Wire
04:39PM  Cohen Milstein Sellers & Toll PLLC Announces Investigation of Meridian Bioscience, Inc. Business Wire
03:30PM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Meridian Bioscience, Inc. Business Wire
Nov-20-17 11:46AM  VIVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Meridian Bioscience, Inc. Business Wire
Nov-17-17 09:35PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. (NASDAQ: VIVO) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and viral diseases, respiratory and parasitic infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the illumigene brand; rapid immunoassays, a single-use immunoassays under the TRU, ImmunoCard, and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the PREMIER brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare brand. This segment's products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens. Its products consists of C. difficile, a causative agent for antibiotic-associated diarrhea from a hospital-acquired infection; foodborne products, such as tests for Enterohemorrhagic E. coli and Campylobacter jejuni; H. pylori to detect stomach ulcers; respiratory products; and women's health and sexually transmitted diseases Group B Streptococcu, Chlamydia trachomatis, Neisseria gonorrhea, and Herpes Simplex Virus Type 1 and Type 2. This segment sells its products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded in 1976 and is headquartered in Cincinnati, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BALDINI LAWRENCEEVP, Global OperationsNov 13Sale19.559,876193,04766,253Nov 14 09:52 AM
BALDINI LAWRENCEEVP, Global OperationsNov 12Sale19.3525,225488,18276,129Nov 14 09:52 AM
McIlwraith JohnDirectorNov 05Option Exercise12.802,00025,6008,000Nov 07 07:53 AM
Ellingwood Dwight EDirectorOct 04Option Exercise12.801,00012,8008,000Oct 04 10:55 AM
McIlwraith JohnDirectorAug 24Buy15.632,00031,2506,000Aug 28 11:34 AM
McIlwraith JohnDirectorFeb 23Buy14.031,00014,0344,000Feb 26 10:50 AM
Rice John McCune Jr.DirectorFeb 07Buy14.751,00014,7501,000Feb 07 03:57 PM